Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/204407
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Dopaminergic control of ADAMTS2 expression through cAMP/CREB and ERK: molecular effects of antipsychotics |
Autor: | Ruso-Julve, Fulgencio; Pombero, Ana CSIC ORCID; Pilar-Cuéllar, Fuencisla CSIC ORCID; García-Díaz, Nuria; Garcia-Lopez, Raquel; Juncal-Ruiz, María; Castro, Elena CSIC ORCID; Díaz, Álvaro CSIC ORCID; Vázquez-Bourgon, Javier; García-Blanco, Agustín; Garro-Martínez, Emilio CSIC ORCID; Pisonero, Helena; Estirado, Alicia CSIC ORCID; Ayesa Arriola, Rosa; López-Giménez, Juan F. CSIC ORCID; Mayor Jr., Federico; Valdizán, Elsa M. CSIC ORCID; Meana, Javier; González-Maeso, Javier; Martínez, Salvador CSIC ORCID; Vaqué, José P. CSIC ORCID; Crespo-Facorro, Benedicto CSIC ORCID CVN | Palabras clave: | Molecular neuroscience Schizophrenia |
Fecha de publicación: | 18-nov-2019 | Editor: | Springer Nature | Citación: | Translational psychiatry 9: 306 (2019) | Resumen: | A better understanding of the molecular mechanisms that participate in the development and clinical manifestations of schizophrenia can lead to improve our ability to diagnose and treat this disease. Previous data strongly associated the levels of deregulated ADAMTS2 expression in peripheral blood mononuclear cells (PBMCs) from patients at first episode of psychosis (up) as well as in clinical responders to treatment with antipsychotic drugs (down). In this current work, we performed an independent validation of such data and studied the mechanisms implicated in the control of ADAMTS2 gene expression. Using a new cohort of drug-naïve schizophrenia patients with clinical follow-up, we confirmed that the expression of ADAMTS2 was highly upregulated in PBMCs at the onset (drug-naïve patients) and downregulated, in clinical responders, after treatment with antipsychotics. Mechanistically, ADAMTS2 expression was activated by dopaminergic signalling (D1-class receptors) and downstream by cAMP/CREB and mitogen-activated protein kinase (MAPK)/ERK signalling. Incubation with antipsychotic drugs and selective PKA and MEK inhibitors abrogated D1-mediated activation of ADAMTS2 in neuronal-like cells. Thus, D1 receptors signalling towards CREB activation might participate in the onset and clinical responses to therapy in schizophrenia patients, by controlling ADAMTS2 expression and activity. The unbiased investigation of molecular mechanisms triggered by antipsychotic drugs may provide a new landscape of novel targets potentially associated with clinical efficacy. | Descripción: | © The Author(s) 2019. | Versión del editor: | http://dx.doi.org/10.1038/s41398-019-0647-7 | URI: | http://hdl.handle.net/10261/204407 | DOI: | 10.1038/s41398-019-0647-7 | E-ISSN: | 2158-3188 |
Aparece en las colecciones: | (IBBTEC) Artículos (IPBLN) Artículos (CBM) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Dopaminergic_Ruso_Julve_Art2019.pdf | 2,05 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
11
checked on 23-abr-2024
SCOPUSTM
Citations
15
checked on 09-may-2024
WEB OF SCIENCETM
Citations
13
checked on 26-feb-2024
Page view(s)
205
checked on 10-may-2024
Download(s)
186
checked on 10-may-2024